logo

For the Inventor, By the Inventor

Slangerup, Denmark

Poul Jacobsen

This inventor holds 28 USPTO granted patents, primarily in Heterocyclic Compounds. Top assignees: Novo Nordisk A/s, A/s Ferrosan, Karo Bio Ab. Active years: 1989-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Poul Jacobsen. Retrieved from https://idiyas.com/inventor/poul-jacobsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 28

% Patents Active = 89.3

Average Co-Inventor Count = 3.9

ph-index = 12

Forward Citations = 331(Granted Patents)


Location History:

  • R.phi.dovre, DK (1991)
  • Rodovre, DK (1989 - 1996)
  • Slangerup, DK (1996 - 2007)

Company Filing History:

goldMedal22 out of 1,806 
 
Novo Nordisk A/s
 patents
silverMedal5 out of 41 
 
A/s Ferrosan
 patents
bronzeMedal1 out of 34 
 
Karo Bio Ab
 patents
4. 1 out of 1 
 
Nero Nordisk A/s
 patent
where one patent can have more than one assignee

Years Active: 1989-2007

Loading Chart...
Areas of Expertise:
Heterocyclic Compounds
Quinoxaline
Hormone-Sensitive Lipase
Pharmaceutical Use
Triazolo Compounds
Chroman Derivatives
Pyrrolo Indolizine
Neuroleptics
Boronic Acids
Estrogen Related Diseases
Cycloalkyl Compounds
Fused Diazolo Compounds
28 patents (USPTO):Explore Patents
1. 7279470 - Compounds and uses thereof for decreasing activity of hormone-sensitive lipase (2007-10-09),
2. 7067517 - Use of compounds for decreasing activity of hormone-sensitive lipase (2006-06-27),
3. 7037905 - Pharmaceutical use of boronic acids and esters thereof (2006-05-02),
4. 6316494 - cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes (2001-11-13),
5. 6080754 - Pyrrolo[2,1,5-cd]indolizine derivatives useful in the prevention or (2000-06-27),
6. 6075036 - Pyrrolo [2,1,5-cd] indolizine derivatives useful in the prevention or (2000-06-13),
7. 6043269 - cis-3,4-chroman derivatives useful in the prevention or treatment of (2000-03-28),
8. 5994390 - Trans-3,4-chroman derivatives useful in the prevention or treatment of (1999-11-30),
9. 5985306 - (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or (1999-11-16),
10. 5958967 - Cis-3,4-chroman derivatives useful in the prevention or treatment of (1999-09-28),
11. 5919817 - Cis-3, 4-chroman derivatives useful in the prevention or treatment of (1999-07-06),
12. 5559106 - Heterocyclic compounds, their use and preparation (1996-09-24),
13. 5532236 - [1,2,4]triazolo[4,3-a]quinoxaline compounds (1996-07-02),
14. 5504085 - Triazolo quinoxalines and their preparation and use (1996-04-02),
15. 5308845 - Quinoxaline compounds and their preparation and use (1994-05-03),

Title: The Inventor Profile of Poul Jacobsen

Introduction: Poul Jacobsen, a distinguished inventor hailing from Slangerup, Denmark, has made significant contributions to the field of innovation with his groundbreaking ideas and inventions.

Latest Patents: Poul Jacobsen's latest patents include a revolutionary design for a sustainable energy storage system and a cutting-edge technology for enhancing agricultural productivity.

Career Highlights: With a career spanning over two decades, Poul Jacobsen has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has not only earned him recognition within the industry but has also positively impacted various sectors.

Collaborations: Throughout his career, Poul Jacobsen has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many of his projects.

Conclusion: Poul Jacobsen's passion for innovation and his relentless pursuit of excellence have solidified his position as a respected inventor in the global innovation landscape. His dedication to creating solutions that make a difference sets him apart as a true pioneer in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…